Investigative site

Boca Raton, Florida 33486

0 studies enrolling now · 3 studies all time

What they study most

Alport Syndrome, Focal Segmental Glomerulosclerosis, Irritable Bowel Syndrome With Diarrhea (IBS-D), Parkinson Disease

Studies at this site

• A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease — Stopped early
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed